Christina K. Isacson
2018
In 2018, Christina K. Isacson earned a total compensation of $2.3M as Chief Business Officer at Dianthus Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $134,000 |
|---|---|
| Option Awards | $1,821,050 |
| Salary | $322,510 |
| Total | $2,277,560 |
Isacson received $1.8M in option awards, accounting for 80% of the total pay in 2018.
Isacson also received $134K in non-equity incentive plan and $322.5K in salary.
Rankings
In 2018, Christina K. Isacson's compensation ranked 5,065th out of 14,244 executives tracked by ExecPay. In other words, Isacson earned more than 64.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,065 out of 14,244 | 64th |
Division Manufacturing | 1,905 out of 5,765 | 67th |
Major group Chemicals And Allied Products | 698 out of 2,128 | 67th |
Industry group Drugs | 584 out of 1,817 | 68th |
Industry Pharmaceutical Preparations | 449 out of 1,391 | 68th |
Source: SEC filing on April 25, 2019.
Isacson's colleagues
We found two more compensation records of executives who worked with Christina K. Isacson at Dianthus Therapeutics in 2018.